193rd Vaccines and Related Biological Products Advisory Committee Meeting
Vaccines and Related Biological Products Advisory Committee (VRBPAC) · June 18, 2026
The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) met June 18, 2026, to review Moderna's BLA for seasonal influenza vaccine mRNA‑1010 for adults 50 and older. The committee voted 9–0 in favor of the vaccine for both age groups after hearing CDC surveillance, outside expert and sponsor data and FDA review.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.